Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 63 results for "cadila pharma"

US FDA grants approval for ezetimibe tablet to Sun Pharma & Zydus Cadila
Business Standard

Zydus Cadila gets USFDA nod for migraine drug

Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine. According to the company, the drug with strengths 20mg and ... SME Times, 1 week ago
Zydus Cadila gets USFDA nod to market migraine drug Business Standard, 1 week ago

30 images for cadila pharma

Money Control, 1 day ago
Money Control, 26 minutes ago
Business Standard, 2 weeks ago
Money Control, 6 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Sify, 2 weeks ago
Sify, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control

Cadila Healthcare aims to double US business to $1 billion in 3 years

Pharma major to launch 100 new products; Moraiya facility slated to come out of US FDA woes
 Business Standard20 hours ago Sun Pharma, Cadila Healthcare recall products from US market  Business Standard2 months ago
Money Control

Stocks in the news: Aurobindo, Cadila, Bajaj Hind, Amtek Auto, Sterlite Tech, NOCIL

Aurobindo Pharma | ONGC | Lupin | HPCL | Cadila Healthcare | IDFC | Bajaj Hindustan Sugar | LT Foods | Bhushan Steel | Amtek Auto | Sterlite Technologies | Jyoti Structures | Grasim and NOCIL are stocks, which are in the news today.
 Money Control1 day ago Stocks in the news: RIL, Aurobindo, Tata Motors, Strides, Titan, Amtek Auto, Cadila  Money Control2 weeks ago Stocks in news: Cipla, Kotak Bank, Infosys, Wockhardt, Cadila  Money Control2 months ago

Cadila up 10%, pips Lupin to become 2nd most valued pharma co

Shares of Cadila Healthcare surged nearly 10 per cent today, helping the company overtake Lupin to become the second most valued pharma firm in terms of market valuation.
 DNA2 weeks ago Cadila Healthcare surpasses Lupin to become 2nd most valuable pharma firm  Business Standard2 weeks ago
Money Control

HDFC Securities positive on Divis, Cadila; neutral on Sun Pharma

In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on a few of the pharma stocks.
 Money Control4 weeks ago
First Post.com

Indian investors ride out big-pharma slump with small-cap drugmakers

MUMBAI - Investors in Indianpharmaceutical stock, hit by quality-related sanctions againstdrugmakers operating abroad and reduced pricing power in moreprofitable markets, have adopted a new mantra: patience andpickiness. Fund managers said they are becoming ...
 Sify1 week ago
Rediff.com

Sensex, Nifty end in the red

Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4% Benchmark indices swung between gains and losses on Friday to end the day flat amid lack of global as well as domestic cues. Nifty50 settled the week 0.8% lower, its first weekly loss in six weeks, breaking its longest gaining streak since late 2014 while Sensex ended the week 0.6% lower. Gains were capped by a sharp correction in pharma and IT stocks on worries over their earnings outlook while ...
 Rediff.com1 week ago
Money Control

Top buzzing midcap stocks to trade on June 15

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- Aurobindo Pharma, Natco Pharma, Cadila, SCI, National Peroxide, Gujarat Alkalies, Ginni Filaments, and Bharti Airtel.
 Money Control1 week ago
Sify

After recent slide, pharma stocks extend recovery

Mumbai: After recent sharp setbacks, the pharmaceutical space is seen some brisk buying this week, and several key stocks in this space have bounced back into the reckoning and gained in strength in the process. Concerns about the observations made by the ...
 Sify3 weeks ago Sensex up 114 points after firm start; Pharma stocks decline  Sify1 month ago Pharma stocks see heavy selling pressure, down up to 6%  Business Standard1 month ago Sensex ends 50 points up  Sify4 weeks ago

IPA punches holes into drug pricing policy implementation

A body of major domestic pharma firms, IPA has hit out at the government over drug price control issue, wondering if the country followed rule of law for the sector. Expressing concern about future of the pharma industry in India, the Indian Pharmaceutical ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less